For Collaborators

• Excellent location in Helsinki at the Meilahti hospital area 
• Serving a population of 2.2 million in the operational area 
• Approximately 700,000 patients treated annually within HUS 
• As HUS offers the whole of Finland specialty care for rare and demanding diseases, special population groups can be included in the studies 
• HUS hospitals handle around 16,000 deliveries annually, enabling expectant mothers and young children to be reached by targeted invitations to studies 
• With 27,000 research-friendly and healthy employees, HUS can motivate participation through internal communication channels 
• Depending on the current needs, specialist doctors and other experts from all medical specialties can be requested to participate in research 

Patient Information System Benefits Research 

• Precise data can be extracted from the Apotti (EPIC) patient information system 
• Real-time data on hospital admissions can be used to closely monitor the study participants’ health status 
• Electronic consent can be requested and signed on the Terveyskylä Omapolku portal 
• Samples can be obtained through the hospital laboratory’s (HUSLAB) sample storage

Storage of Vaccines and Samples

• Stored at either +4°C, -20°C, or -80°C 
• Equipment temperatures are monitored 
• Backup power-connected refrigeration ensures reliable storage for vaccines and samples 

Sample Collection 

• Blood, urine, and stool samples, as well as skin and mucous membrane swabs and skin biopsies, can be collected at the centre 
• Samples are processed and stored at the centre 
• Sample collection can be arranged with HUSLAB according to specific requirements

Contracts, Budget, and Invoicing 

Contracts and financial matters are managed through the HYKS Institute. To access their webpage, please click here.

Meilahti Vaccine Research Center (MeVac) 
vaccine@hus.fi
tel. +358 50 311 6365

Address:
Biomedicum Helsinki 1
Haartmaninkatu 8
00290 Helsinki